Cardiac Biotech Solutions, Inc. (CBSC)
0.0356
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Cardiac Biotech Solutions SG&A Expense (TTM) : 0.4266M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4266M |
| March 31, 2026 | 0.3963M |
| December 31, 2025 | 0.5459M |
| September 30, 2025 | 0.5976M |
| June 30, 2025 | 0.9425M |
| March 31, 2025 | 1.196M |
| December 31, 2024 | 0.9978M |
| September 30, 2024 | 1.111M |
| June 30, 2024 | 1.237M |
| March 31, 2024 | 1.389M |
| December 31, 2023 | 3.175M |
| September 30, 2023 | 2.685M |
| June 30, 2023 | 2.399M |
| March 31, 2023 | 2.142M |
| December 31, 2022 | 1.264M |
| September 30, 2022 | 1.582M |
| June 30, 2022 | 1.447M |
| March 31, 2022 | 23.32M |
| December 31, 2021 | 23.32M |
| September 30, 2021 | 23.35M |
| Date | Value |
|---|---|
| June 30, 2021 | 24.89M |
| March 31, 2021 | 2.922M |
| December 31, 2020 | 2.013M |
| September 30, 2020 | 1.651M |
| June 30, 2020 | 0.0573M |
| March 31, 2020 | 0.0113M |
| December 31, 2019 | 0.0537M |
| June 30, 2019 | 0.0537M |
| March 31, 2019 | 0.7319M |
| December 31, 2018 | 0.7319M |
| September 30, 2018 | 1.087M |
| June 30, 2018 | 1.100M |
| March 31, 2018 | 0.4472M |
| December 31, 2017 | 0.4805M |
| September 30, 2017 | 0.0774M |
| June 30, 2017 | 0.1129M |
| March 31, 2017 | 0.1212M |
| December 31, 2016 | 0.088M |
| September 30, 2016 | 0.0851M |
| June 30, 2016 | 0.0367M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vyome Holdings, Inc. | 2.683M |
| Abbott Laboratories | 13.94B |
| AngioDynamics, Inc. | 157.09M |
| Alphatec Holdings, Inc. | 524.06M |
| AtriCure, Inc. | 323.68M |